Back to calendar
Halozyme Therapeutics, Inc. (HALO) Earnings
HALO reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $1.79
Actual EPS: $1.60
EPS surprise: 3.56%
Company overview
Market Cap$9.8B
PriceUSD 82.47
P/E29.66
EPS (TTM)2.78
52-week high83.50
52-week low57.67
SectorHealth Technology
IndustryBiotechnology
Employees423